VAT00008
Title:
A parallel-group, Phase III, multistage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older
Acronym:
VAT00008
Timeline:
2021 – 2023
Status:
Completed
Funder:
SANOFI
Objective
The major goals of this project are to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent) in adults 18 years of age and older.